Severe septic inflammation as a strong stimulus of myocardial NT-pro brain natriuretic peptide release

International Journal of Cardiology

Volumn 122, Issue 2, 2007, Pages 131-136

  Wolff, Birger ^a   Haase, Detlef ^a   Lazarus, Peter ^a   Machill, Klaus ^a   Graf, Bernhard ^a   Lestin, Heiko Gundmar ^a   Werner, Dierk ^a  

^a HELIOS KLINIKEN SCHWERIN   (Germany)

Author keywords

Acute coronary syndrome; Intensive care; NT proBNP; Septic shock

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; APACHE; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; NECROSIS; PEPTIDE FRAGMENTS; PROGNOSIS; SHOCK, SEPTIC; SYNDROME;

EID: 35148845187     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.051     Document Type: Article

References (26)

1. Hunt P.J., Yandle T.G., Nicholls M.G., Richards A.M., and Espiner E.A. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 214 (1995) 1175-1183
2. Goetze J.P. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem 50 (2004) 1503-1510
3. Bay M., Kirk V., Parner J., et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 89 (2003) 150-154
4. Talwar S., Squire I.B., Downie P.F., et al. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. Eur Heart J 21 (2000) 1514-1521
5. Pruszczyk P., Kostrubiec M., Bochowicz A., et al. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J 22 (2003) 649-653
6. Tomcsanyi J., Marosi A., Bozsik B., et al. N-terminal pro-brain natriuretic peptide and tombstoning ST-segment elevation in patients with anterior wall acute myocardial infarction. Am J Cardiol 96 (2005) 1197-1199
7. Verges B., Zeller M., Desgres J., et al. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock. Eur Heart J 26 (2005) 1734-1741
8. Jernberg T., James S., Lindahl B., Stridsberg M., Venge P., and Wallentin L. NT-proBNP in unstable coronary artery disease-experiences from the FAST, GUSTO IV and FRISC II trials. Eur J Heart Fail 6 (2004) 319-325
9. Jernberg T., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 42 (2003) 1909-1916
10. Abdullah S.M., Khera A., Das S.R., et al. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am J Cardiol 96 (2005) 1284-1289
11. Kragelund C., Gronning B., Kober L., Hildebrandt P., and Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352 (2005) 666-675
12. Chua G., and Kang-Hoe L. Marked elevations in N-terminal brain natriuretic peptide levels in septic shock. Crit Care 8 (2004) 248-250
13. Roch A., Allardet-Servent J., Michelet P., et al. NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 33 (2005) 1001-1007
14. Brueckmann M., Huhle G., Lang S., et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 112 (2005) 527-534
15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864-874
16. Schiller N.B., Acquatella H., Ports T.A., et al. Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation 60 (1979) 547-555
17. Witthaut R., Busch C., Fraunberger P., et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 29 (2003) 1696-1702
18. Nugent A.M., Onuoha G.N., McEneaney D.J., et al. Variable patterns of atrial natriuretic peptide secretion in man. Eur J Clin Invest 24 (1994) 267-274
19. Hammerer-Lercher A., Puschendorf B., and Mair J. Cardiac natriuretic peptides: new laboratory parameters in heart failure patients. Clin Lab 47 (2001) 265-277
20. Januzzi J.L., Morss A., Tung R., et al. Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study. Crit Care 10 (2006) R37
21. Knebel F., Schimke I., Pliet K., et al. NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation. J Card Fail 11 (2005) S38-S41
22. Forfia P.R., Watkins S.P., Rame J.E., Stewart K.J., and Shapiro E.P. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 45 (2005) 1667-1671
23. Hopkins W.E., Chen Z., Fukagawa N.K., et al. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 109 (2004) 2872-2877
24. Court O., Kumar A., Parrillo J.E., and Kumar A. Clinical review: myocardial depression in sepsis and septic shock. Crit Care 6 (2002) 500-508
25. Kumar A., Bunnell E., Lynn M., et al. Experimental human endotoxemia is associated with depression of load-independent contractility indices: prevention by the lipid A analogue E5531. Chest 126 (2004) 860-867
26. Kumar A., Thota V., Dee L., et al. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183 (1996) 949-958